1. Home
  2. AOMR vs PGEN Comparison

AOMR vs PGEN Comparison

Compare AOMR & PGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AOMR
  • PGEN
  • Stock Information
  • Founded
  • AOMR 2018
  • PGEN 1998
  • Country
  • AOMR United States
  • PGEN United States
  • Employees
  • AOMR N/A
  • PGEN N/A
  • Industry
  • AOMR Real Estate Investment Trusts
  • PGEN Biotechnology: Pharmaceutical Preparations
  • Sector
  • AOMR Real Estate
  • PGEN Health Care
  • Exchange
  • AOMR Nasdaq
  • PGEN Nasdaq
  • Market Cap
  • AOMR 240.9M
  • PGEN 248.7M
  • IPO Year
  • AOMR 2021
  • PGEN N/A
  • Fundamental
  • Price
  • AOMR $9.85
  • PGEN $0.91
  • Analyst Decision
  • AOMR Buy
  • PGEN Buy
  • Analyst Count
  • AOMR 6
  • PGEN 5
  • Target Price
  • AOMR $11.70
  • PGEN $7.00
  • AVG Volume (30 Days)
  • AOMR 106.3K
  • PGEN 749.9K
  • Earning Date
  • AOMR 11-05-2024
  • PGEN 11-07-2024
  • Dividend Yield
  • AOMR 12.98%
  • PGEN N/A
  • EPS Growth
  • AOMR N/A
  • PGEN N/A
  • EPS
  • AOMR 1.97
  • PGEN N/A
  • Revenue
  • AOMR $69,248,000.00
  • PGEN $4,389,000.00
  • Revenue This Year
  • AOMR N/A
  • PGEN N/A
  • Revenue Next Year
  • AOMR $30.57
  • PGEN $211.35
  • P/E Ratio
  • AOMR $5.01
  • PGEN N/A
  • Revenue Growth
  • AOMR N/A
  • PGEN N/A
  • 52 Week Low
  • AOMR $7.85
  • PGEN $0.82
  • 52 Week High
  • AOMR $13.32
  • PGEN $1.93
  • Technical
  • Relative Strength Index (RSI)
  • AOMR 31.11
  • PGEN 45.66
  • Support Level
  • AOMR $9.83
  • PGEN $0.86
  • Resistance Level
  • AOMR $10.07
  • PGEN $0.92
  • Average True Range (ATR)
  • AOMR 0.16
  • PGEN 0.05
  • MACD
  • AOMR 0.02
  • PGEN 0.01
  • Stochastic Oscillator
  • AOMR 7.46
  • PGEN 59.31

About AOMR Angel Oak Mortgage REIT Inc.

Angel Oak Mortgage REIT Inc is a real estate finance company focused on acquiring and investing in the first lien non-QM loans and other mortgage-related assets in the U.S. mortgage market. Its objective is to generate attractive risk-adjusted returns for its stockholders, through cash distributions and capital appreciation, across interest rates and credit cycles.

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

Share on Social Networks: